Bye-law 2, National Medical Commission (Fees of The sale of drugs) Bye-laws, 2023 [SAY-CGR]

As at 7 September 2026. In force from 2 January 2023.

In National Medical Commission (Fees of The sale of drugs) Bye-laws, 2023 [R1G-M8S]. This text from 2 January 2023. No other text held.

Synthetic. This instrument, its title, its number and the words of this section are generated by the register.

Cite: Bye-law 2, National Medical Commission (Fees of The sale of drugs) Bye-laws, 2023 [SAY-CGR]. Machine: SAY-CGR.

Definitions.—In these bye-laws, unless the context otherwise requires,— (a) "Act" means the National Medical Commission Act, 2019 (30 of 2019); (b) "licensee" means a person carrying on the sale of drugs; (c) "stock register" means a stock register received, held or disposed of by a licensee in the course of the sale of drugs; (d) "Form 25" means the form so numbered in the Schedule; (e) words and expressions used herein and not defined but defined in the Act shall have the meanings respectively assigned to them in the Act.

Defined terms in this text (0)

none

Made under this bye-law, or naming it (0)

none

Cited by (0)

none

Not held (0)

none

Duties published under this bye-law (0)

none